Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:34:10.761Z.
Calculation as of: 2026-10-06T16:34:10.761Z.
Quote observation: 2026-10-06T16:28:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ff2bb50ee92c82d9bafac158d2b6876f5ec2ee6c7e034d44b6b8dcedc71e7a96
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2020-08-07.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$5.23M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.23M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.29M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.20M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmatrix, Inc. (PULM) | $5.41M | N/A | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | N/A | N/A | N/A | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | N/A | N/A | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.23M | N/A | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.29M | N/A | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.20M | N/A | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | N/A | N/A | N/A | N/A |
| Soligenix, Inc. (SNGX)vs › | $5.34M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.02M | N/A | 11.91x | 14.69x | 14.69x |
| CalciMedica, Inc. (CALC)vs › | $4.63M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2020-08-07 | 0.26x |
| 2020-08-06 | 0.31x |
| 2020-08-05 | 0.31x |
| 2020-08-04 | 0.34x |
| 2020-08-03 | 0.31x |
| 2020-07-31 | 0.43x |
| 2020-07-30 | 0.40x |
| 2020-07-29 | 0.31x |
| 2020-07-28 | 0.29x |
| 2020-07-27 | 0.29x |
| 2020-07-24 | 0.37x |
| 2020-07-23 | 0.48x |
| 2020-07-22 | 0.48x |
| 2020-07-21 | 0.59x |
| 2020-07-20 | 0.54x |
| 2020-07-17 | 0.62x |
| 2020-07-16 | 0.71x |
| 2020-07-15 | 0.65x |
| 2020-07-14 | 0.48x |
| 2020-07-13 | 0.51x |
| 2020-07-10 | 0.96x |
| 2020-07-09 | 1.30x |
| 2020-07-08 | 2.13x |
| 2020-07-07 | 1.82x |
| 2020-07-06 | 1.65x |
| 2020-07-02 | 1.51x |
| 2020-07-01 | 1.63x |
| 2020-06-30 | 1.54x |
| 2020-06-29 | 1.85x |
| 2020-06-26 | 1.99x |
| 2020-06-25 | 2.02x |
| 2020-06-24 | 2.07x |
| 2020-06-23 | 2.18x |
| 2020-06-22 | 2.24x |
| 2020-06-19 | 1.79x |
| 2020-06-18 | 1.60x |
| 2020-06-17 | 1.37x |
| 2020-06-16 | 1.40x |
| 2020-06-15 | 1.32x |
| 2020-06-12 | 1.04x |
| 2020-06-11 | 1.01x |
| 2020-06-10 | 1.29x |
| 2020-06-09 | 1.43x |
| 2020-06-08 | 1.35x |
| 2020-06-05 | 1.51x |
| 2020-06-04 | 1.26x |
| 2020-06-03 | 1.40x |
| 2020-06-02 | 1.46x |
| 2020-06-01 | 1.32x |
| 2020-05-29 | 1.43x |
| 2020-05-28 | 1.51x |
| 2020-05-27 | 1.93x |
| 2020-05-26 | 1.90x |
| 2020-05-22 | 1.99x |
| 2020-05-21 | 2.10x |
| 2020-05-20 | 1.99x |
| 2020-05-19 | 1.54x |
| 2020-05-18 | 1.21x |
| 2020-05-15 | 0.98x |
| 2020-05-14 | 3.08x |
| 2020-05-13 | 3.27x |
| 2020-05-12 | 2.82x |
| 2020-05-11 | 2.82x |
| 2020-05-08 | 2.18x |
| 2020-05-07 | 2.12x |
| 2020-05-06 | 1.80x |
| 2020-05-05 | 1.67x |
| 2020-05-04 | 1.80x |
| 2020-05-01 | 1.54x |
| 2020-04-30 | 1.67x |
| 2020-04-29 | 2.12x |
| 2020-04-28 | 1.41x |
| 2020-04-27 | 1.70x |
| 2020-04-24 | 2.37x |
| 2020-04-23 | 1.03x |
| 2020-04-22 | 0.96x |
| 2020-04-21 | 1.03x |
| 2020-04-20 | 1.35x |
| 2020-04-17 | 0.84x |
| 2020-04-16 | 4.17x |
| 2020-04-15 | 3.53x |
| 2020-04-14 | 3.08x |
| 2020-04-13 | 3.72x |
| 2020-04-09 | 1.99x |
| 2020-04-08 | 1.35x |
| 2020-04-07 | 1.16x |
| 2020-04-06 | 1.16x |
| 2020-04-03 | 0.90x |
| 2020-04-02 | 1.03x |
| 2020-04-01 | 1.03x |
| 2020-03-27 | 0.20x |
| 2020-03-11 | 0.04x |
| 2020-03-10 | 0.39x |
| 2020-03-09 | 0.57x |
| 2020-03-06 | 1.75x |
| 2020-03-05 | 1.74x |
| 2020-03-04 | 1.39x |
| 2020-03-03 | 1.51x |
| 2020-03-02 | 1.69x |
| 2020-02-28 | 1.34x |
| 2020-02-27 | 0.10x |
| 2020-02-26 | 0.10x |
| 2020-02-25 | 0.10x |
| 2020-02-24 | 0.39x |
| 2020-02-21 | 0.98x |
| 2020-02-20 | 1.22x |
| 2020-02-19 | 1.10x |
| 2020-02-18 | 1.63x |
| 2020-02-14 | 0.69x |
| 2020-02-13 | 0.39x |
| 2020-02-12 | 0.39x |
| 2020-02-11 | 0.27x |
| 2020-02-10 | 0.75x |
| 2020-02-07 | 0.92x |
| 2020-02-06 | 0.86x |
| 2020-02-05 | 1.28x |
| 2020-02-04 | 1.39x |
| 2020-02-03 | 1.75x |
| 2020-01-31 | 1.75x |
| 2020-01-30 | 2.22x |
| 2020-01-29 | 2.63x |
| 2020-01-28 | 2.40x |
| 2020-01-27 | 1.51x |
| 2020-01-24 | 1.45x |
| 2020-01-23 | 1.34x |
| 2020-01-22 | 1.22x |
| 2020-01-21 | 1.39x |
| 2020-01-17 | 1.51x |
| 2020-01-16 | 1.04x |
| 2020-01-15 | 0.80x |
| 2020-01-14 | 0.80x |
| 2020-01-13 | 0.51x |
| 2020-01-10 | 1.04x |
| 2020-01-09 | 0.98x |
| 2020-01-08 | 0.75x |
| 2020-01-07 | 0.86x |
| 2020-01-06 | 1.28x |
| 2020-01-03 | 0.80x |
| 2020-01-02 | 1.45x |